Haematological cancer: Where are we now with the treatment of multiple myeloma?
Nat Rev Clin Oncol
.
2017 Aug;14(8):461-462.
doi: 10.1038/nrclinonc.2017.82.
Epub 2017 Jun 13.
Authors
Gareth J Morgan
1
,
Leo Rasche
1
Affiliation
1
Myeloma Institute, University of Arkansas for Medical Sciences, 4301 W. Markham, Little Rock, Arkansas 72205, USA.
PMID:
28607521
DOI:
10.1038/nrclinonc.2017.82
No abstract available
Publication types
Comment
MeSH terms
Bortezomib
Dexamethasone
Hematologic Neoplasms*
Humans
Lenalidomide
Multiple Myeloma*
Substances
Bortezomib
Dexamethasone
Lenalidomide